Research on the Anti-tumor Mechanism of Natural Antimicrobial Peptide TA

Journal: Journal of Clinical Medicine Research DOI: 10.32629/jcmr.v7i1.5056

Guofang Feng, Yang Wan

Jiangxi University of Traditional Chinese Medicine, Nanchang 330004, Jiangxi, China

Abstract

Natural antimicrobial peptides exhibit broad-spectrum antibacterial properties and the capacity to selectively eradicate tumour cells, presenting a promising avenue for the development of innovative anti-cancer medications[1,2]. Among these peptides, TA is a significant natural antimicrobial peptide currently undergoing investigation for its anti-tumour efficacy. This investigation focuses on human non-small cell lung cancer cells (A549 cells) as the experimental model. Cell morphology will be examined using scanning electron microscopy, while the mitochondrial membrane potential changes in A549 cells following various drug treatments will be monitored in real-time using the mitochondrial membrane potential probe DiSC3(5). The overall cell count and apoptotic cell distribution will be assessed alongside DAPI/PI double staining to elucidate the mechanism and effectiveness of TA in inducing cell death in A549 cells. Intriguingly, our experiments have revealed that TA can trigger the apoptotic pathway by disrupting the mitochondrial membrane potential of A549 cells, demonstrating significantly greater cytotoxicity compared to 5-FU and PT compounds. These findings provide empirical support for considering TA as a potential therapeutic option for lung cancer and propose a novel strategy for targeted therapy of non-small cell lung cancer.

Keywords

natural antimicrobial peptide TA; anti-tumor mechanism of action; cell apoptosis

References

[1]Liu Mengyue, Liu Shanshan, Fu Chao, et al. Design of the New Bullfrog anti-tumor Peptide RGD-T-La(FS) chimera and its anti-tumor effect [J]. Journal of Chinese veterinary medicine, 2018, 38 (01) : 39-50.
[2]Wan Lanlan. Study on the anti-tumor effect and mechanism of TT-1 Polypeptide on TT Cells and its combination with IFN-α on HepG2 cells [D]. Jilin University,2016.
[3] Yang W,Qinkun G,Kaisen C, et al.Development of Therapeutic Gramicidin S Analogues Bearing Plastic β,γ-DiaminoAcids.[J].ChemMedChem,2020,15(12):1089-1100.
[4] Chengfei H,Quan W,Shuhui H, et al.Corrigendum: Gramicidin-S-Inspired Cyclopeptidomimetics as Potent Membrane-Active Bactericidal Agents with Therapeutic Potential.[J].ChemMedChem,2022,17(3):e202100765-e202100765.
[5] Jibao Z,Chengfei H,Zizhen Z, et al.Polymyxin B-inspired Non-hemolytic Tyrocidine A Analogues with Significantly Enhanced Activity Against Gram-negative Bacteria: How Cationicity Impacts Cell Specificity and Antibacterial Mechanism[J].European Journal of Medicinal Chemistry,2021,221(prepublish):113488.
[6] Qinkun G,Shuhui H,Yi J, et al.Recent Advances in the Exploration of Therapeutic Analogues of Gramicidin S, an Old but Still Potent Antimicrobial Peptide.[J].Journal of medicinal chemistry,2019,62(17):7603-7617.
[7] Chai, Y.; Yu, Can.; Chen, Z.; Duan, W.; Chen, H.; Qiu, X.; Xu, Z.; Liu, S.; Danilenko, A.; Frison, G.; Alezra, V.; Miclet, E.; Li, Xiang.; Wan, Y. Rapid C-S+ Bond Cleavage via 1,6-Benzyl Elimination for Traceless Modification of Bioactive Peptides. J. Am. Chem. Soc. 2025,147, 20807−20818.
[8] He, F.; Chai, Y.; Zeng, Z.; Lu, F.; Chen, H.; Zhu, J.; Fang, Y.; Cheng, K.; Miclet, E.; Alezra, V.; Wan, Y. Rapid Formation of Intramolecular Disulfide Bridges Using Light: An Efficient Method to Control the Conformation and Function of Bioactive Peptides. J. Am. Chem. Soc. 2023,145,22639−22648.
[9] Zeng, Z.; Zhu, J.; Deng, X.; Chen, H.; Jin, Y.; Miclet, E.; Alezra, V.; Wan, Y. Customized Reversible Stapling for Selective Delivery of Bioactive Peptides. J. Am. Chem. Soc. 2022, 144 (51), 23614–23621.

Copyright © 2026 Guofang Feng, Yang Wan

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License